Search for: "Novartis International AG"
Results 41 - 60
of 120
Sort by Relevance
|
Sort by Date
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
26 May 2015, 7:42 am
(Emphasis added).FDA Regulation of Pharmacogenomic InformationWe still feel the same way, but now with the caveat that the FDA is starting to lay the regulatory foundation for drug warnings in the coming age of personalized medicine. [read post]
25 May 2015, 4:15 am
.* When functionality cuts deep, it can be hard to handle: Yoshida appeal dismissedValentina's back again to pen on General Court's decision in Joined Cases C‑337/12 P to C‑340/12 P Pi-Design AG, Bodum France SAS and Bodum Logistics A/S v OHIM, Yoshida Metal Industry Co. [read post]
18 May 2015, 11:01 am
The Court of Justice of the European Union (CJEU) addresses that issue in Dimensione Direct Sales srl and Michele Labianca v Knoll International SpA, C-516/13 -- and so does Eleonora in this post.* "Now Now, mere reputation is not enough for passing-off" says Supreme CourtIn Starbucks (HK) Limited and another v British Sky Broadcasting Group plc and others [2015] UKSC 31, the UK Supreme Court rejected arguments that it should expand its jurisprudence on… [read post]
11 May 2015, 3:05 pm
If you were one of those people and missed a batch of Katposts, you can check them all out below.Once again the IPKat is indebted to his good and amiable friend Alberto Bellan, who has sampled all the posts and has this to report:* A Kat visits #INTA15: PreludeThe International Trademark Association (INTA) has held its 137th Meeting in San Diego this year, deep in the sunny south of California. [read post]
3 May 2015, 10:33 pm
.* No toleration for Novartis - rivastigmine patch patent declared invalidDarren writes up Mr Justice Arnold’s fresh decision in Novartis v Focus, Actavis, Teva [2015] EWHC 1068 (Pat).No cats are skinned, but publisher is "Berned" for Chesterton infringementValentina reports on a Spanish Supreme Court’s decision in a very peculiar Spanish copyright case, where the principle of non-discrimination is addressed and a copyright term of protection is held… [read post]
31 Mar 2015, 4:01 pm
They would mean that libraries can acquire and lend commercially available digital materials and, with archives, can continue to underpin knowledgeable societies in the digital age. [read post]
19 Mar 2015, 5:00 am
Novartis AG, ___ F. [read post]
2 Mar 2015, 2:43 pm
It is all about patent law and how subject matter ‘relates’ to other subject matter, he explains. ***** PREVIOUSLY, ON NEVER TOO LATE Never too late 34 [week ending Sunday 22 February] – Bill Gates goes to China | Ms Swift's issue with trade marks | TMs and jurisdiction for on-line infringement cases | UK's Chartered Institute of Patent Attorneys and the EPO | Divani & Divani | UK first in global IP enforcement | SUEPO v EPO | Enterprise v Europcar[2015] EWHC 300 |… [read post]
23 Feb 2015, 2:55 am
.* The Richemont ruling and beyond: dealing with counterfeit websites and the intermediaries that host themKatfriend Tim Behean provides another insightful analysis of Cartier International AG and Others v British Sky Broadcasting Ltd and Others [2014] EWHC 3354 (Ch) [following Eleonora's Katpost here], explaining what Arnold J's decision has achieved, how they go about dealing with blocking injunctions in the United States -- and where we might go… [read post]
16 Feb 2015, 1:44 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
9 Feb 2015, 1:15 am
* International Intellectual Property: a Handbook of Contemporary ResearchJeremy announces the publication of The Research Handbook on International Intellectual Property, an Edward Elgar Publishing volume which is edited by Daniel J. [read post]
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
15 Dec 2014, 7:25 am
* * *When Trademarks Overlap With Other IP Rights Special* * *"When Trademarks Overlap with Other IP Rights" is the International Trademark Association’s (INTA) European winter conference that took place last week in the lovely city of Munich. [read post]
9 Dec 2014, 3:50 am
He cited the VODKAT and Rihanna cases [Katposts here and here] which appear to suggest that case law has not actually moved very far from its original position.Next to speak was Myrtha Hurtado Rivas (Novartis AG), who gave a strategic overview of the trade mark v unfair competition position from the standpoint of a business that had to make decisions as to how -- and where -- to enforce its rights and protect its interests in the Europe of today -- and beyond. [read post]
25 Aug 2014, 9:35 am
Novartis Pharm. [read post]
3 Feb 2014, 9:51 pm
Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
16 Jan 2014, 7:31 pm
Procedural HistoryNovartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation (collectively, Novartis) filed suits that challenged the determinations by the Patent and Trademark Office of how much time to add, under 35 U.S.C. [read post]
